Mesoblast Annual Report
As of August 2020, our patent portfolio includes the following patents and patent applications in the following major jurisdictions: 82 granted U.S. patents and 49 pending U.S. patent applications; 61 granted Japanese patents and 29 pending Japanese patent applications; 27 granted Chinese patents and 24 pending Chinese patent applications; 55 granted European patents and 29 pending European patent applications; and 58 granted Australian patents and 30 pending Australian patent applications.
JB- Op asked whether you were across patents for cryopreservation - hinting that may be a concern for CYP. Do you have a response? I have a lot of reading to do
as there are many granted Mesoblast US patents , not so many for Cynata.
Cynata annual report
Notable progress on patents owned directly by Cynata include the following:
z Notices of Acceptance/Allowance from IP
Australia and the Canadian Intellectual Property
Office (CIPO) regarding a patent application
entitled “Colony Forming Medium and Use
Thereof”, which relates to the optimisation of the
Cymerus process by Cynata.
Operating and Financial Review 21
z Notices of Allowance from the US Patent Office
and the CIPO for a patent application entitled
“Pluripotent Stem Cell Assay”, which relates to a
novel method for ensuring the quality and purity of
Cynata’s therapeutic MSC products
z A Notice of Acceptance from IP Australia for a
patent application titled “Method for Treating
Allergic Airways Disease (AAD/Asthma)”,
describes a method of use of Cymerus MSC
products in treating diseases of the lungs and
airways
Reg
- Forums
- ASX - By Stock
- MSB
- Bell Potter Conference Up dates?
Bell Potter Conference Up dates?, page-168
-
- There are more pages in this discussion • 78 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
|
|||||
Last
$1.03 |
Change
0.080(8.42%) |
Mkt cap ! $1.176B |
Open | High | Low | Value | Volume |
95.5¢ | $1.03 | 95.0¢ | $43.38M | 42.28M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 72752 | $1.01 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.03 | 205100 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 20000 | 1.005 |
5 | 57985 | 1.000 |
1 | 50000 | 0.995 |
2 | 20525 | 0.990 |
1 | 10000 | 0.985 |
Price($) | Vol. | No. |
---|---|---|
1.035 | 190122 | 7 |
1.045 | 39714 | 5 |
1.050 | 21696 | 6 |
1.060 | 9750 | 2 |
1.065 | 5780 | 1 |
Last trade - 16.10pm 30/08/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |
The Watchlist
CCO
THE CALMER CO INTERNATIONAL LIMITED
Anthony Noble, MD & CEO
Anthony Noble
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online